Finzati - Logo
INTI logo

Inhibitor Therapeutics, Inc.

INTI • Biotechnology
$0.11
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$19.06M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Healthy liquidity · 3.19Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:17 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.11
Change0.00%
Shares Out173.31M
Market Cap$19.06M
Enterprise Value$18.60M
52W Range0.04 - 0.12
Beta-0.71
P/E-5.76
P/B-7.45
P/FCF-5.92
EV/EBITDA-5.57
EV/FCF-5.77

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Healthy liquidity · 3.19Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 9/13/2013
Industry: Biotechnology
P/B i: -7.45
Debt / Equity i: -0.05
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: -0.05
Current Ratio: 3.19
Quick Ratio: 3.19
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Black Robe Capital LLC
Transaction: 07/01/2026
SELL
Change
-3,200,000
Price
Not reported
Filing
08/04/2026
Type
SELL
ODONNELL FRANCIS E JR
Transaction: 05/04/2026
BUY
Change
+50,000
Price
Not reported
Filing
08/04/2026
Type
BUY
SEARS SAMUEL P JR
Transaction: 05/04/2026
BUY
Change
+50,000
Price
Not reported
Filing
08/04/2026
Type
BUY